SCHEMBL14955873

SCHEMBL14955873

COC(=O)c1cc(C)c(F)cc1Br

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOS1 Q07889 1/20 0.44
KMT2A Q03164 1/20 0.42
LMNA P02545 2/20 0.40
TSHR P16473 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HDAC1 Q13547 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
NOTUM Q6P988 2/20 0.38
SLC6A3 Q01959 1/20 0.38
MAPT P10636 1/20 0.38
CA12 O43570 2/20 0.37
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
CA7 P43166 2/20 0.37
CA9 Q16790 2/20 0.37
CA14 Q9ULX7 2/20 0.37
LCK P06239 1/20 0.37
FYN P06241 1/20 0.37
PDK2 Q15119 1/20 0.37
PDK4 Q16654 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21352107 0.93 SOS1 (0.44) SOS1KMT2ALMNATSHRNPSR1
SCHEMBL709908 0.87 SOS1 (0.47) SOS1KMT2ALMNATSHRNPSR1
SCHEMBL850400 0.86 SOS1 (0.44) SOS1KMT2ALMNATSHRNPSR1
SCHEMBL31024710 0.85 MAPT (0.42) SOS1LMNATSHRHDAC1HDAC6
SCHEMBL3436881 0.85 MAPT (0.42) SOS1LMNATSHRHDAC1HDAC6
SCHEMBL18432612 0.85 KMT2A (0.46) SOS1KMT2ALMNATSHRNOTUM
SCHEMBL20470613 0.83 PDGFRB (0.42) KMT2ALMNATSHRHDAC1HDAC6
SCHEMBL14186809 0.83 MAPT (0.41) LMNATSHRHDAC1HDAC6SLC6A3
SCHEMBL20036871 0.83 KMT2A (0.44) SOS1KMT2ALMNATSHRNOTUM
SCHEMBL14349262 0.81 SOS1 (0.50) SOS1KMT2ALMNATSHRNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119948034-A Novel peptide-based nitrile compound and application thereof 上海壹迪生物技术有限公司 2025-05-06 CN disclosed
CN-117964637-A Novel peptide-based nitrile compound and application thereof 上海壹迪生物技术有限公司 2024-05-03 CN disclosed
WO-2024088307-A1 NOVEL PEPTIDYL NITRILE COMPOUND AND USE THEREOF 上海壹迪生物技术有限公司 2024-05-02 WO disclosed
EP-2782448-B1 BORON-CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS INC (US) 2017-08-16 EP disclosed
EP-2782448-B1 BORON-CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS INC (US) 2017-08-16 EP disclosed
US-20160000813-A1 BORON-CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS, INC. 2016-01-07 US disclosed
US-20160000813-A1 BORON-CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS, INC. 2016-01-07 US disclosed
US-20160000813-A1 BORON-CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS, INC. 2016-01-07 US disclosed
US-9156860-B2 Boron-containing small molecules ANACOR PHARMACEUTICALS, INC. (US) 2015-10-13 US disclosed
US-9156860-B2 Boron-containing small molecules ANACOR PHARMACEUTICALS, INC. (US) 2015-10-13 US disclosed
US-20150025038-A1 BORON-CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS, INC. 2015-01-22 US disclosed
US-8853186-B2 Boron containing small molecules ANACOR PHARMACEUTICALS, INC. (US) 2014-10-07 US disclosed
US-8853186-B2 Boron containing small molecules ANACOR PHARMACEUTICALS, INC. (US) 2014-10-07 US disclosed
US-8853186-B2 Boron containing small molecules ANACOR PHARMACEUTICALS, INC. (US) 2014-10-07 US disclosed
EP-2782448-A1 BORON-CONTAINING SMALL MOLECULES Anacor Pharmaceuticals, Inc. (US) 2014-10-01 EP disclosed
WO-2013078070-A1 BORON-CONTAINING SMALL MOLECULES ELI LILLY AND COMPANY (US) 2013-05-30 WO disclosed
WO-2013078070-A1 BORON-CONTAINING SMALL MOLECULES ELI LILLY AND COMPANY (US) 2013-05-30 WO disclosed
US-20130131016-A1 BORON-CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS, INC. (US) 2013-05-23 US disclosed
US-20130131016-A1 BORON-CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS, INC. (US) 2013-05-23 US disclosed
US-20130131016-A1 BORON-CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS, INC. (US) 2013-05-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160000813-A1 BORON-CONTAINING SMALL MOLECULES BCL6B, SLC7A5, BCL6 SOS1 2738/4885KMT2A 2331/4885LMNA 2352/4885
US-20130131016-A1 BORON-CONTAINING SMALL MOLECULES BCL6B, SLC7A5, BCL6 SOS1 2738/4885KMT2A 2331/4885LMNA 2352/4885
US-20150025038-A1 BORON-CONTAINING SMALL MOLECULES BCL6B, SLC7A5, BCL6 SOS1 2738/4885KMT2A 2331/4885LMNA 2352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.